⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9716225 | 0.72 | MEN1 (0.48) | — | |
| SCHEMBL1944623 | 0.69 | — | — | |
| SCHEMBL10531007 | 0.68 | — | — | |
| SCHEMBL1982621 | 0.68 | — | — | |
| SCHEMBL844033 | 0.68 | — | — | |
| SCHEMBL9478739 | 0.68 | — | — | |
| SCHEMBL13180500 | 0.68 | — | — | |
| SCHEMBL174893 | 0.68 | — | — | |
| SCHEMBL1438047 | 0.68 | — | — | |
| SCHEMBL1629942 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350232-B | Preparation method of 1- (3-bromopyridine-2-yl) ethanone | 山东佰隆医药有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119350232-A | Preparation method of 1- (3-bromopyridine-2-yl) ethanone | 山东佰隆医药有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119241497-A | Preparation method of 5- (5-bromopyridine) tetrazole | 上海若济生物医药科技有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-102219735-A | Method for preparing 2-sulfydryl-5-bromine-N-pyridine oxide | UNIV XUZHOU NORMAL | 2011-10-19 | — | — | CN | claimed |
| WO-2025264645-A1 | SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE | LATIGO BIOTHERAPEUTICS, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-12503438-B2 | Compounds for the treatment of kinase-dependent disorders | EXELIXIS, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| CN-119350232-B | Preparation method of 1- (3-bromopyridine-2-yl) ethanone | 山东佰隆医药有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119350232-B | Preparation method of 1- (3-bromopyridine-2-yl) ethanone | 山东佰隆医药有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119350232-A | Preparation method of 1- (3-bromopyridine-2-yl) ethanone | 山东佰隆医药有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119350232-A | Preparation method of 1- (3-bromopyridine-2-yl) ethanone | 山东佰隆医药有限公司 | 2025-01-24 | — | — | CN | disclosed |
| US-20250011315-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | PRISM MEDICINES, INC. | 2025-01-09 | — | — | US | disclosed |
| CN-119241497-A | Preparation method of 5- (5-bromopyridine) tetrazole | 上海若济生物医药科技有限公司 | 2025-01-03 | — | — | CN | disclosed |
| US-5354749-A | For treating arterial hypertension and atheroschlerosis | BAYER AKTIENGESELLSCHAFT (DE) | 1994-10-11 | — | — | US | disclosed |
| CN-1082029-A | The pyridone that Biphenylmethyl replaces | BAYER AG (DE) | 1994-02-16 | — | — | CN | disclosed |
| CN-1080923-A | Benzo pyridone and pyridopyridine ketone that Sulphonylbenzyl replaces | BAYER AG (DE) | 1994-01-19 | — | — | CN | disclosed |
| WO-1992018092-A2 | 1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-10-29 | — | — | WO | disclosed |
| EP-0508445-A1 | 1-Arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of circulatory disorders | G.D. Searle & Co. (US) | 1992-10-14 | — | — | EP | disclosed |
| US-5155117-A | Hypotensive agents | G. D. SEARLE & CO. (US) | 1992-10-13 | — | — | US | disclosed |
| US-5141931-A | 5-Quinolinylpyridinones, cardiotonic compositions and methods | STERLING WINTHROP INC. (US) | 1992-08-25 | — | — | US | disclosed |
| US-4017477-A | 3-Halogeno-6-hydroxy-pyridone-(2) azo dyestuffs | CIBA-GEIGY AG (CH) | 1977-04-12 | — | — | US | disclosed |